1. Introduction {#sec1-molecules-24-01248}
===============

Leishmaniasis is a collection of parasitic diseases caused by several *Leishmania* species \[[@B1-molecules-24-01248],[@B2-molecules-24-01248]\]. The disease is transmitted by several members of Phlebotominae sand flies. The genera *Lutzomyia* (New World) and *Phlebotomus* (Old World) are the only hematophagous vectors of the diseases. Leishmaniasis is considered by the World Health Organization to be a neglected tropical disease \[[@B3-molecules-24-01248]\]. Depending on the *Leishmania* species, the disease can manifest itself in three main forms: cutaneous, mucocutaneous, and visceral. There are currently around 12--15 million people worldwide infected by *Leishmania* spp. with an estimated 350 million people at risk of acquiring leishmaniasis. Unfortunately, at the present time, there are no vaccines or prophylactic medicines available to prevent the disease. Current chemotherapeutic treatment options include sodium stibogluconate, meglumine antimoniate, conventional (deoxycholate) and liposomal amphotericin B, pentamidine isethionate, miltefosine and paromomycin. However, these agents suffer from severe side effects, poor efficacy, limited availability, high cost, or developing resistance \[[@B2-molecules-24-01248],[@B4-molecules-24-01248]\]. Furthermore, treatment of leishmaniasis is often hampered by limited access to medicines and treatment options in developing countries where the disease is prevalent \[[@B5-molecules-24-01248],[@B6-molecules-24-01248]\].

Essential oils are complex mixtures of volatile phytochemicals with numerous and varied biological properties \[[@B7-molecules-24-01248],[@B8-molecules-24-01248]\]. Essential oils, particularly those that are readily available, may provide low cost treatment options for leishmaniasis. The antiparasitic activities of essential oils and their components have been demonstrated and previously reviewed \[[@B9-molecules-24-01248],[@B10-molecules-24-01248]\]. Commercially available EOs have been screened for activity against a variety of human pathogens \[[@B11-molecules-24-01248],[@B12-molecules-24-01248],[@B13-molecules-24-01248],[@B14-molecules-24-01248],[@B15-molecules-24-01248],[@B16-molecules-24-01248],[@B17-molecules-24-01248]\] as well as for cytotoxic activity \[[@B12-molecules-24-01248],[@B16-molecules-24-01248]\]. In this work, we carried out in-vitro antileishmanial and cytotoxic screening of a selection of 52 commercially available essential oils against the promastigote form of *Leishmania amazonensis* and peritoneal macrophages from BALB/c, respectively. Promising antileishmanial essential oils were further screened against intracellular amastigotes.

2. Results and Discussion {#sec2-molecules-24-01248}
=========================

A total of 52 commercially-available essential oils were screened for in-vitro antileishmanial activity against the promastigote form of *L. amazonensis*, as well as for cytotoxic activity against mouse peritoneal macrophages, the host cells for the amastigote form of the parasite. The antileishmanial and cytotoxic activities of the essential oils are summarized in [Table 1](#molecules-24-01248-t001){ref-type="table"}. Of the essential oils tested, three showed notable antileishmanial activity and selectivity, frankincense oil (from the oleogum resin of *Boswellia* spp.), coriander oil (from the seeds of *Coriandrum sativum* L.), and wintergreen oil (from the leaves of *Gualtheria fragrantissima* Wall.). These three products were also active against the intracellular amastigote form of *L. amazonensis* ([Table 2](#molecules-24-01248-t002){ref-type="table"}).

The cluster analysis revealed four clusters based on biological activities ([Figure 1](#molecules-24-01248-f001){ref-type="fig"}). Cluster 1 is made up of essential oils that showed good antileishmanial activity with little or no cytotoxicity. The very large cluster 2 can be described as essential oils that showed relatively weak antileishmanial activity and relatively weak cytotoxic activity, cluster 3 is composed of essential oils with both moderate antileishmanial activity but also with moderate cytotoxic activity, and cluster 4 is made up of essential oils that were very cytotoxic.

The active cluster (Cluster 1) can be subdivided into two sub-clusters made up of coriander (*Coriandrum sativum*) and frankincense (*Boswellia* spp.), Cluster 1a, and Cluster 1b, wintergreen (*Gualtheria fragrantissima*) and birch bark (*Betula lenta* L.). Frankincense is the oleogum resin from several *Boswellia* species. Commercial frankincense sources include *B. sacra* Flueck., *B. carteri* Birdw., *B. frereana* Birdw., *B. papyrifera* Hochst. and *B. serrata* Roxb. Commercial frankincense essential oil from doTERRA International is a proprietary blend of largely *B. carteri*, followed by *B. sacra*, *B. papyrifera*, and *B. freriana*. Analysis of the essential oil used in this investigation revealed that it is composed largely of monoterpenes, including α-pinene (41.2%), α-thujene (15.7%), limonene (9.4%), sabinene (4.5%), β-pinene (3.5%), and *p*-cymene (3.3%), as well as octyl acetate (5.4%) and β-caryophyllene (3.1%). Frankincense essential oil showed activity against promastigotes and amastigotes of *L. amazonensis* with IC~50~ values of \<12.5 and 22.1 ± 4.2 μg/mL, respectively. Consistent with the antiparasitic activity of frankincense essential oil, Fujisaki and co-workers screened *B. carteri* essential oil against *Plasmodium falciparum* and the oil was shown to have an IC~50~ of 10 μg/mL \[[@B18-molecules-24-01248]\]. α-Pinene itself has shown activity against both promastigotes (IC~50~ 19.7 μg/mL) and amastigotes (IC~50~ 16.1 μg/mL) of *L. amazonensis* \[[@B19-molecules-24-01248]\].

Another essential oil rich in α-pinene was cypress (*Cupressus sempervirens* L.) with 49.7% α-pinene. Cypress essential oil gave an IC~50~ of 40.0 μg/mL against *L. amazonensis* promastigotes, but was too cytotoxic (CC~50~ 27.2 μg/mL) against mouse peritoneal macrophages to be considered for further evaluation. Other major components in cypress essential oil were δ-3-carene (27.0%) and terpinolene (4.2%). Juniper (*Juniperus communis* L.) berry essential oil was also dominated by α-pinene (34.9%), with lesser quantities of myrcene (11.9%), sabinene (11.4%), β-pinene (7.9%), and terpinen-4-ol (4.5%). Juniper berry essential oil showed good activity against *L. amazonensis* promastigotes (IC~50~ 27.4 μg/mL) and reduced cytotoxicity against mouse peritoneal macrophages (CC~50~ 103.0 μg/mL). Thus, the presence of α-pinene seems to impart antileishmanial activity, but the activity is apparently enhanced or attenuated by other components in the essential oil.

Coriander is the fruit of *C. sativum*. Commercial coriander essential oil used in this study was obtained from dōTERRA International and the major components were linalool (73.5%), α-pinene (5.3%), and γ-terpinene (4.5%). A linalool-rich (73.2%) coriander essential oil was screened by Rondon and co-workers against *Leishmania chagasi* and was shown to be very effective against amastigotes (IC~50~ 1.51 μg/mL), but much less active against the promastigotes (IC~50~ 181 μg/mL) \[[@B20-molecules-24-01248]\]. It is tempting to speculate that linalool might be the compound responsible for the antileishmanial activity. Indeed, Rosa and co-workers have shown linalool to be very active against both promastigotes (IC~50~ 0.0043 μg/mL) and amastigotes (IC~50~ 0.0155 μg/mL) of *L. amazonensis* \[[@B21-molecules-24-01248]\]. However, the presence of linalool does not necessarily translate to a good antileishmanial profile. Pettitgrain (*Citrus aurantium* L.) leaf essential oil (25.4% linalool), lavender (*Lavandula angustifolia* Mill.) essential oil (34.4% linalool), and basil (*Ocimum basilicum* L.) essential oil (55.7% linalool), were only marginally active against *L. amazonensis* promastigotes (IC~50~ 56.9, 70.7, and \>200 μg/mL, respectively). There may be other components in these essential oils attenuating the antileishmanial activity of linalool.

Interestingly, wintergreen (*Gualtheria fragrantissima*) essential oil, which was dominated by methyl salicylate (99.7%), showed antileishmanial activity against both *L. amazonensis* promastigotes (IC~50~ 20.7 μg/mL) and amastigotes (IC~50~ 22.2 μg/mL). *Betula lenta* (birch bark) essential oil (99.9% methyl salicylate) was somewhat less active against *L. amazonensis* promastigotes (IC~50~ 32.2 μg/mL). Considering the abundance of methyl salicylate in both wintergreen and birch essential oils, this compound is likely the active component.

Copaiba oils (not hydrodistilled essential oils) from several different species of *Copaifera* were screened by Santos and collaborators against *L. amazonensis* \[[@B22-molecules-24-01248]\]. Antileishmanial activities against the promastigotes ranged from 5.0 to 22.0 μg/mL. Consistent with these results, copaiba oil in this study (50% β-caryophyllene) showed an IC~50~ of 17.2 μg/mL. The copaiba essential oil, however, was also too cytotoxic (CC~50~ 23.3 μg/mL) to warrant further consideration. On the other hand, β-caryophyllene was found to be remarkably active against *L. amazonensis* amastigotes (IC~50~ 1.3 μg/mL) but less toxic to murine macrophages (CC~50~ 63.6 μg/mL) \[[@B23-molecules-24-01248]\]. In contrast, antipromastigote activity of β-caryophyllene on *L. amazonensis* was reported to have an IC~50~ of 19 μg/mL \[[@B24-molecules-24-01248]\]. β-Caryophyllene was also found to show excellent antileishmanial activity against *L. infantum* and *L. major* (IC~50~ 1.06 and 1.33 μg/mL, respectively), with less cytotoxicity against Raw 264.7 mouse macrophage cells \[[@B25-molecules-24-01248]\].

Rosemary (*Rosmarinus officinalis* L.) essential oil from Colombia (composition not reported) showed activity against *L. braziliensis* promastigotes with an IC~50~ of 17.4 μg/mL \[[@B26-molecules-24-01248]\]. Similarly, rosemary essential oil from Tunisia (43.8% 1,8-cineole, 12.0% camphor, 11.5% α-pinene, 8.6% β-pinene, 4.8% camphene) was active against *L. infantum* (IC~50~ 16.3 μg/mL) and *L. major* (IC~50~ 20.9 μg/mL) promastigotes \[[@B25-molecules-24-01248]\]. Conversely, a commercial rosemary essential oil obtained in Germany was inactive against *L. major* promastigotes (IC~50~ 282 μg/mL) \[[@B11-molecules-24-01248]\]. In this present study, commercial rosemary essential oil (45.9% 1,8-cineole, 12.0% α-pinene, 10.9% camphor, 6.3% β-pinene) was only marginally antileishmanial (IC~50~ 89.7 μg/mL), but also marginally cytotoxic (CC~50~ 83.4 μg/mL). Rosemary essential oils have shown great variation in composition with at least five different chemotypes, which likely result in different biological activities \[[@B27-molecules-24-01248]\].

Mikus and co-workers have screened several essential oils and essential oil components for antileishmanial activity against *L. major* promastigotes \[[@B11-molecules-24-01248]\]. These workers found commercial *Melissa officinalis* L. essential oil to show excellent activity against *L. major* promastigotes (IC~50~ 7.0 μg/mL) with less toxicity against HL-60 (human leukemia) cells (CC~50~ 25.5 μg/mL). Andrade and co-workers screened a commercial *M. officinalis* essential oil (37.2% neral, 52.0% geranial) and fount marginal activity against *L. amazonensis* promastigotes with an IC~50~ of 132 μg/mL \[[@B17-molecules-24-01248]\]. In contrast, *M. officinalis* essential oil from Colombia was inactive against *L. braziliensis* promastigotes \[[@B26-molecules-24-01248]\]. In this present work, *M. officinalis* essential oil showed antileishmanial activity (IC~50~ 24.6 μg/mL) but also cytotoxicity (CC~50~ 37.3 μg/mL) giving it an unfavorable selectivity index. The major components in *M. officinalis* essential oil were β-caryophyllene (13.4%), geranial (30.2%), and neral (23.1%). Citral, a mixture of geranial and neral, has shown antileishmanial activity against *L. infantum*, *L. tropica*, and *L. major* promastigotes with IC~50~ values of 42, 34, and 36 μg/mL, respectively \[[@B28-molecules-24-01248]\]. However, citral has demonstrated in-vitro cytotoxic activity against several cell lines \[[@B29-molecules-24-01248],[@B30-molecules-24-01248],[@B31-molecules-24-01248]\]. There are several chemotypes of *M. officinalis* based on essential oil composition, which likely account for the differences in biological activities. Nevertheless, the citral chemotype of *M. officinalis* has also shown in-vitro cytotoxicity \[[@B32-molecules-24-01248]\].

Likewise, the unfavorable bioactivity profile of lemongrass (*Cymbopogon flexuosus* (Nees) Will. Watson) essential oil in this study is likely due to the abundance of geranial (49.9%) and neral (23.4%). However, Machado and co-workers found that citral-rich *C. citratus* as well as citral did not exhibit cytotoxic effects on either primary bovine aortic endothelial cells or RAW 264.7 macrophage cells \[[@B28-molecules-24-01248]\]. Similarly, Santin and co-workers found both *C. citratus* essential oil and citral to be antileishmanial against promastigotes (IC~50~ 1.7 and 8.0 μg/mL, respectively) and amastigotes (IC~50~ 3.2 and 25.0 μg/mL, respectively) of *L. amazonensis*, but with lower cytotoxicity against J774G8 macrophage cells \[[@B33-molecules-24-01248]\].

As has been appreciated, many pure components present in the tested EOs have exhibited some level of antileishmanial activity. In fact, it is known that the compounds present in the EOs can act synergistically in mixtures, increasing the intrinsic effects of the purified components. Therefore, we suggest the potential use of EOs as mixtures. In addition, we have also taken into account that the tested EOs are commercially available in their present forms, reducing the cost of a therapeutic alternative, which constitutes one of main drawbacks of current antileishmanial treatments. The notable antileishmanial effects and moderate cytotoxicities in the case of mixtures of compounds could be further explored in animal models of cutaneous leishmaniasis by intralesional or topical routes.

3. Materials and Methods {#sec3-molecules-24-01248}
========================

3.1. Essential Oils {#sec3dot1-molecules-24-01248}
-------------------

The essential oils were obtained from commercial sources, dōTERRA International (Pleasant Grove, UT, USA), Ameo Essential Oils (Zija International, Lehi, UT, USA), Mountain Rose Herbs (Eugene, OR, USA), or Albert Vielle (Vallauris, France) and were previously analyzed by gas chromatography--mass spectrometry.

3.2. Parasites {#sec3dot2-molecules-24-01248}
--------------

*Leishmania amazonensis* parasites (Reference strain MHOM/77/BR/LTB0016) were kindly provided by the Department of Immunology, Oswaldo Cruz Foundation (FIOCRUZ), Brazil. The parasites were routinely isolated from mouse lesions (BALB/c mice) and maintained as promastigotes at 26 °C in Schneider's medium (Sigma-Aldrich, St. Louis, MO, USA) containing 10% heat-inactivated fetal bovine serum (HFBS) (Sigma-Aldrich, St. Louis, MO, USA) and 100 U of penicillin and 100 μg streptomycin per mL as antibiotics. Parasite cultures were passaged every 3--4 days, but no longer used after the tenth passage after isolation from mice.

3.3. In-vitro Anti-promastigote Screening {#sec3dot3-molecules-24-01248}
-----------------------------------------

Screening against *L. amazonensis* promastigotes was carried out as previously described \[[@B34-molecules-24-01248],[@B35-molecules-24-01248],[@B36-molecules-24-01248]\]. Into each well in a 96-well plate, 50 μL medium (Schneider's medium + HFBS + antibiotics) was added. Into the wells of column 2 and 7, 48 μL medium + 2 μL sample (dimethylsulfoxide solutions of essential oil, 20 mg/mL) were added. Five two-fold serial dilutions were carried out down each column to give final test concentrations of 12.5, 25, 50, 100 and 200 μg/mL. Exponentially growing parasites (4 × 10^5^) in medium were added to each well. Dimethylsulfoxide (DMSO) served as the negative control and pentamidine (Richet, Buenos Aires, Argentina) was used as a positive control. The plates were sealed with Parafilm^®^ and incubated at 26 °C for 72 h. Afterward, 20 μL of a solution (5 mg/mL) of MTT (3-\[4,5-dimethylthiazol-2-yl\]-2,5-diphenyltetrazolium bromide) (Sigma-Aldrich, St. Louis, MO, USA) was added to each well. The plates were incubated for an additional 4 h, the supernatant was removed, and the formazan crystals were dissolved with 100 μL DMSO. The absorbance of each well was determined with a plate reader (Molecular Devices, San Jose, CA, USA) with a test wavelength of 560 nm and a reference wavelength of 630 nm from which median inhibitory concentrations (IC~50~) were calculated \[[@B37-molecules-24-01248],[@B38-molecules-24-01248]\]. The IC~50~ values were determined from linear dose-response curves fit to the data using a linear equation model. Each test was carried out in triplicate, and the results expressed as means ± standard deviations (SD).

3.4. Mouse Peritoneal Macrophage Cytotoxicity Screening {#sec3dot4-molecules-24-01248}
-------------------------------------------------------

The median cytotoxic concentrations (CC~50~) of the essential oils on mouse peritoneal macrophages (the host cells of *Leishmania* parasites) were determined as previously described \[[@B34-molecules-24-01248],[@B35-molecules-24-01248],[@B36-molecules-24-01248]\]. Macrophages were collected from the peritoneal cavities of normal BALB/c mice and suspended in ice-cold RPMI 1640 medium (Sigma-Aldrich, St. Louis, MO, USA), supplemented with antibiotics. The cells were seeded in 96-well plates (3 × 10^5^ cells/well) and incubated at 37 °C for 2 h. Non-adherent cells were removed. Into the wells of column 2 and 7, 2 μL of essential oil solutions (as above) and 48 μL medium (supplemented with 10% HFBS and antibiotics) were also added. Two-fold serial dilutions down each lane were carried out to give final concentrations of 12.5--200 μg/mL. The macrophages were incubated for 72 h, after which the cytotoxicity was determined using the MTT assay (as above), using 15 μL/well. The CC~50~ was calculated for each compound in the same manner as the IC~50~ and selectivity indices (SI) for each essential oil were determined (CC~50~ for macrophages / IC~50~ for promastigotes).

Essential oils with an IC~50~ \< 100 µg/mL and a SI ≥ 5 were selected for further evaluation against *L. amazonensis* amastigotes \[[@B34-molecules-24-01248]\].

3.5. In-vitro Intracellular Anti-amastigote Screening {#sec3dot5-molecules-24-01248}
-----------------------------------------------------

Median inhibitory concentrations (IC~50~) of the active essential oils on *L. amazonensis* amastigotes were carried out as previously described \[[@B34-molecules-24-01248],[@B35-molecules-24-01248],[@B36-molecules-24-01248]\]. The peritoneal macrophages, obtained from BALB/c mice (as above), were seeded in 24-well culture plates at 10^6^ cells/mL. The plates were incubated at 37 °C under a 5% CO~2~ atmosphere for 2 h. Non-adherent cells were removed, and stationary-phase *L. amazonensis* promastigotes were added (4:1 promastigote/macrophage ratio), and incubation continued for an additional 4 h. Free parasites were removed and 1000 μL RPMI completed medium was added to each well. Into the first well, 990 μL medium and 10 μL essential oil solution were added. Four two-fold dilutions were carried out to give final concentrations of 12.5, 25, 50 and 100 μg/mL. The plate was incubated at 37 °C under a 5% CO~2~ atmosphere for 48 h. The cell monolayers were fixed in absolute methanol, stained with Giemsa, and evaluated using a light microscope. The number of intracellular amastigotes was determined by counting 25 macrophages per sample. The results are expressed as percent reduction of infection rate (% infected macrophages × number amastigotes per infected macrophage) compared to that of the controls. The IC~50~ values were determined from the concentration-response linear curves. Each evaluation was carried out in triplicate and the results expressed as means ± SD.

3.6. Hierarchical Cluster Analysis {#sec3dot6-molecules-24-01248}
----------------------------------

The chemical compositions of the commercial essential oils along with the antileishmanial and cytotoxic activities were used in an agglomerative hierarchical cluster (AHC) analysis. The essential oil compositions of the 52 commercially-available essential oils and the bioactivities were used to determine the associations between the essential oils and their activities using XLSTAT Premium, version 2018.5.53172 (Addinsoft, Paris, France). Dissimilarity was determined using Euclidean distance, and clustering was defined using Ward's method.

4. Conclusions {#sec4-molecules-24-01248}
==============

This study has shown that the essential oils of frankincense, coriander, wintergreen, and birch have notable antiparasitic activities against *Leishmania amazonensis* with an acceptable SI with respect to cytotoxicity against mouse peritoneal macrophages. However, essential oils are complex mixtures of compounds, and the biological activities cannot necessarily be attributed to individual components; there are apparent synergistic and/or antagonistic interactions as well. Nevertheless, essential oils containing appreciable concentrations of α-pinene, linalool, or methyl salicylate should be investigated for antiparasitic activity.
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###### 

Screening of 52 essential oils against *Leishmania amazonensis* promastigotes and BALB/c mouse peritoneal macrophages.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Essential Oil                                                  Commercial\     IC~50~ ± SD (μg/mL)\   CC~50~ ± SD (μg/mL)\   Selectivity\   Comments
                                                                 Source          Promastigotes\         Macrophage\            Index (SI)     
                                                                                 *L. amazonensis*       from BALB/c mice                      
  -------------------------------------------------------------- --------------- ---------------------- ---------------------- -------------- ----------------------
  *Abies sibirica* Ledeb. (Siberian fir)                         dōTERRA         58.2 ± 8.5             42.5 ± 2.4             1              Unspecific

  *Anthemis nobilis* L. (Roman chamomile)                        dōTERRA         27.9 ± 4.5             85.7 ± 6.0             3              Unspecific

  *Betula lenta* L. (birch)                                      dōTERRA         32.2 ± 6.6             136.8 ± 9.2            4              Unspecific

  ***Boswellia*** **Roxb. ex Colebr. spp. (frankincense)**       **dōTERRA**     **\<12.5**             **59.3 ± 1.8**         **5**          **Active/Follow up**

  *Cananga odorata* (Lam.) Hook. f. & Thomson (ylang ylang)      dōTERRA         36.6 ± 3.9             55.6 ± 0.5             2              Unspecific

  *Cinnamomum zeylanicum* Blume (cinnamon bark)                  dōTERRA         \<12.5                 \<12.5                 \-             Too Toxic

  *Cistus ladanifer* L. (cistus)                                 Albert Vielle   19.2 ± 4.6             56.9 ± 8.1             3              Unspecific

  *Citrus aurantium* L. (pettitgrain)                            dōTERRA         56.9 ± 1.8             77.4 ± 0.9             1              Unspecific

  *Citrus aurantium* L. (wild orange)                            dōTERRA         34.8 ± 2.2             35.2 ± 1.7             1              Unspecific

  *Citrus aurantifolia* Swingle (lime)                           dōTERRA         \<12.5                 \<12.5                 \-             Too toxic

  *Citrus* × *bergamia* Risso & Poit. (bergamot)                 dōTERRA         59.2 ± 6.3             44.9 ± 1.6             1              Unspecific

  *Citrus limon* (L.) Osbeck (lemon)                             dōTERRA         71.2 ± 1.9             71.1 ± 1.6             1              Unspecific

  *Citrus* × *paradisi* Macfad. (grapefruit)                     dōTERRA         35.5 ± 4.4             \<12.5                 \-             Too Toxic

  *Citrus reticulata* Blanco (tangerine)                         dōTERRA         70.7 ± 7.8             54.3 ± 1.0             1              Unspecific

  *Commiphora myrrha* (T. Nees) Engl. (myrrh)                    dōTERRA         \<12.5                 \<12.5                 \-             Too Toxic

  ***Coriandrum sativum* L. (coriander)**                        **dōTERRA**     **\<12.5**             **141.7 ± 4.1**        **\>8**        **Active/Follow up**

  *Coriandrum sativum* L. (cilantro)                             dōTERRA         34.4 ± 4.8             45.9 ± 1.3             1              Unspecific

  *Copaifera* L. spp. (copaiba)                                  dōTERRA         17.2 ± 0.1             23.3 ± 7.1             1              Unspecific

  *Cupressus sempervirens* L. (cypress)                          Améo            40.0 ± 2.3             27.2 ± 0.7             1              Unspecific

  *Cymbopogon flexuosus* (Nees) Will. Watson (lemongrass)        dōTERRA         27.8 ± 0.4             30.0 ± 2.0             1              Unspecific

  *Elettaria cardamomum* (L.) Maton (cardamom)                   dōTERRA         109.5 ± 1.3            60.5 ± 6.0             1              Unspecific

  *Eugenia caryophyllata* Thunb.\                                dōTERRA         \>200                  143.1 ± 11.9           \-             Inactive
  (syn. *Syzygium aromaticum* (L.) Merr. & L.M. Perry) (clove)                                                                                

  *Eucalyptus radiata* Sieber ex DC. (eucalyptus)                dōTERRA         164.7 ± 8.3            100.2 ± 8.4            1              Unspecific

  *Foeniculum vulgare* Mill. (sweet fennel)                      dōTERRA         \>200                  66.9 ± 7.9             \-             Inactive

  ***Gualtheria fragrantissima* Wall.(wintergreen)**             **dōTERRA**     **20.7 ± 1.6**         **135.4 ± 5.7**        **7**          **Active/Follow up**

  *Helichrysum italicum* G. Don f. (helichrysum)                 Améo            42.8 ± 2.2             55.2 ± 2.4             1              Unspecific

  *Juniperus communis* L. (juniper berry)                        Améo            27.4 ± 0.5             103.0 ± 9.3            4              Unspecific

  *Juniperus virginiana* L. (cedarwood)                          dōTERRA         53.2 ± 8.4             \<12.5                 \-             Too Toxic

  *Lavandula angustifolia* Mill. (lavender)                      Améo            70.7 ± 5.0             82.3 ± 2.4             1              Unspecific

  *Melaleuca alternifolia* Cheel (tea tree)                      dōTERRA         70.7 ± 6.2             42.5 ± 1.4             1              Unspecific

  *Melissa officinalis* L. (melissa)                             dōTERRA         24.6 ± 0.7             37.3 ± 1.4             2              Unspecific

  *Mentha piperita* L. (peppermint)                              dōTERRA         172.8 ± 4.1            67.3 ± 4.4             0              Unspecific

  *Mentha spicata* L. (spearmint)                                dōTERRA         79.8 ± 3.0             90.4 ± 5.6             1              Unspecific

  *Myristica fragrans* Houtt. (nutmeg)                           Améo            133.5 ± 2.6            40.0 ± 1.1             0              Unspecific

  *Nardostachys jatamansi* (D. Don) DC. (spikenard)              dōTERRA         49.8 ± 1.4             22.1 ± 4.0             0              Unspecific

  *Nepeta cataria* L. (catnip)                                   Mountain Rose   54.0 ± 4.4             81.6 ± 0.8             2              Unspecific

  *Ocimum basilicum* L. (basil)                                  dōTERRA         \>200                  69.1 ± 9.0             \-             Inactive

  *Origanum majorana* L. (marjoram)                              dōTERRA         \>200                  25.7 ± 1.3             \-             Inactive

  *Origanum vulgare* L. (oregano)                                dōTERRA         \>200                  66.5 ± 0.9             \-             Inactive

  *Pelargonium graveolens* L\'Hér. ex Aiton (geranium)           Améo            \>200                  57.4 ± 3.6             \-             Inactive

  *Piper nigrum* L. (black pepper)                               dōTERRA         57.7 ± 3.7             35.6 ± 5.7             1              Unspecific

  *Pogostemon cablin* (Blanco) Benth. (patchouli)                Améo            68.7 ± 7.8             \<12.5                 \-             Too Toxic

  *Pseudotsuga menziesii* (Mirb.) Franco (Douglas fir)           dōTERRA         82.5 ± 4.5             37.7 ± 3.2             0              Unspecific

  *Rosmarinus officinalis* L. (rosemary)                         dōTERRA         89.7 ± 2.0             83.4 ± 7.3             1              Unspecific

  *Santalum album* L. (Indian sandalwood)                        dōTERRA         105.5 ± 6.0            29.9 ± 6.3             0              Unspecific

  *Santalum paniculatum* Hook. & Arn. (Hawaiian sandalwood)      dōTERRA         43.1 ± 2.2             25.9 ± 5.3             1              Unspecific

  *Salvia sclarea* L. (clary sage)                               Améo            \>200                  58.6 ± 9.0             \-             Inactive

  *Tanacetum annuum* L. (blue tansy)                             dōTERRA         52.2 ± 2.8             36.6 ± 5.8             1              Unspecific

  *Thuja plicata* Donn ex D. Don (arborvitae)                    dōTERRA         67.1 ± 3.1             61.9 ± 6.1             1              Unspecific

  *Thymus vulgaris* L. (thyme)                                   dōTERRA         \>200                  30.5 ± 5.5             \-             Inactive

  *Vetiveria zizanioides* (L.) Nash\                             dōTERRA         19.0 ± 3.3             31.7 ± 2.8             2              Unspecific
  (syn. *Chrysopogon zizanioides* (L.) Roberty) (vetiver)                                                                                     

  *Zingiber officinale* Roscoe (ginger)                          dōTERRA         39.9 ± 3.4             58.3 ± 4.7             1              Unspecific

  Pentamidine                                                                    0.37 ± 0.01            11.7 ± 1.7             31             **Active**
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------

IC~50~: Median inhibitory concentration. Concentration that inhibits 50% of promastigote growth. CC~50~: Median cytotoxic concentration. Concentration that causes the mortality of 50% of macrophages. SD: Standard deviation. SI: Selectivity index: CC~50~/IC~50.~ In bold, essential oils that were selected as active and selective.
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###### 

Screening of frankincense, coriander, and wintergreen essential oils against *Leishmania amazonensis* intracellular amastigotes.

  Essential Oil                               IC~50~ ± SD (µg/mL)   SI
  ------------------------------------------- --------------------- ----
  *Boswellia* spp. (frankincense)             22.1 ± 4.2            2
  *Coriandrum sativum* (coriander)            19.1 ± 0.7            7
  *Gualtheria fragrantissima* (wintergreen)   22.2 ± 3.5            6
  Pentamidine                                 1.3 ± 0.1             9

IC~50~: Median inhibitory concentration. Concentration that inhibits 50% of promastigote growth. SD: Standard deviation. SI: Selectivity index: CC~50~/IC~50.~
